CollPlant Biotechnologies (CLGN) Income towards Parent Company (2017 - 2025)
CollPlant Biotechnologies filings provide 9 years of Income towards Parent Company readings, the most recent being -$2.8 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company rose 25.41% to -$2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.3 million, a 268.46% decrease, with the full-year FY2025 number at -$11.1 million, up 32.76% from a year prior.
- Income towards Parent Company hit -$2.8 million in Q4 2025 for CollPlant Biotechnologies, up from -$3.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $10.1 million in Q1 2021 to a low of -$4.7 million in Q4 2022.
- Median Income towards Parent Company over the past 5 years was -$2.9 million (2021), compared with a mean of -$87750.0.
- Biggest five-year swings in Income towards Parent Company: surged 735.13% in 2021 and later tumbled 191.07% in 2022.
- CollPlant Biotechnologies' Income towards Parent Company stood at -$3.8 million in 2021, then dropped by 22.92% to -$4.7 million in 2022, then increased by 6.03% to -$4.4 million in 2023, then grew by 13.93% to -$3.8 million in 2024, then increased by 25.41% to -$2.8 million in 2025.
- The last three reported values for Income towards Parent Company were -$2.8 million (Q4 2025), -$3.5 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.